Association Between Immune‐Related Adverse Events and Treatment Outcomes in Advanced Gastric Cancer Patients Receiving Nivolumab Plus Chemotherapy: A Retrospective Study

ABSTRACT Background Immune‐related adverse events (irAEs) have been linked to improved outcomes in patients undergoing treatment with immune checkpoint inhibitors (ICIs) for various cancers. However, the relationship between irAEs and overall survival (OS) in patients with advanced gastric cancer (A...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Cancer Medicine
المؤلفون الرئيسيون:	Kazumasa Yamamoto, Hidekazu Hirano, Toshiharu Hirose, Hirokazu Shoji, Natsuko Okita, Atsuo Takashima, Ken Kato
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley 2025-09-01
الموضوعات:	advanced gastric cancer chemotherapy immune checkpoint inhibitor (ICI) immune‐related adverse event (irAE)
الوصول للمادة أونلاين:	https://doi.org/10.1002/cam4.71252